West Pharmaceutical Services, Inc.
WST
$303.45
-$8.62-2.76%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 138.80M | 132.10M | 140.00M | 131.80M | 89.80M |
| Total Depreciation and Amortization | 45.20M | 47.00M | 43.00M | 41.40M | 40.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.80M | -9.70M | 12.10M | 8.00M | -500.00K |
| Change in Net Operating Assets | -102.90M | 81.70M | 2.10M | -4.10M | 100.00K |
| Cash from Operations | 89.90M | 251.10M | 197.20M | 177.10M | 129.40M |
| Capital Expenditure | -42.70M | -76.10M | -63.30M | -75.20M | -71.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -42.70M | -76.10M | -63.30M | -75.20M | -71.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -300.00K | -300.00K | -300.00K | -300.00K | -200.00K |
| Issuance of Common Stock | 7.50M | 4.60M | 4.00M | 5.20M | 4.40M |
| Repurchase of Common Stock | -300.10M | -200.00K | -100.00K | -500.00K | -136.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.80M | -15.80M | -15.10M | -15.10M | -15.20M |
| Other Financing Activities | -- | 0.00 | 0.00 | -4.20M | -- |
| Cash from Financing | -308.70M | -11.70M | -11.50M | -14.90M | -147.00M |
| Foreign Exchange rate Adjustments | -8.40M | -500.00K | -3.60M | 18.50M | 8.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -269.90M | 162.80M | 118.80M | 105.50M | -80.40M |